 |
PDBsum entry 2er6
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
2er6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.23.22
- endothiapepsin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Hydrolysis of proteins with broad specificity similar to that of pepsin A, preferring hydrophobic residues at P1 and P1', but does not cleave 14-Ala-|-Leu-15 in the B chain of insulin or Z-Glu-Tyr. Clots milk.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Eur J Biochem
169:215-221
(1987)
|
|
PubMed id:
|
|
|
|
|
| |
|
The structure of a synthetic pepsin inhibitor complexed with endothiapepsin.
|
|
J.Cooper,
S.Foundling,
A.Hemmings,
T.Blundell,
D.M.Jones,
A.Hallett,
M.Szelke.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The conformation of a synthetic polypeptide inhibitor, bound to the active site
of the fungal aspartic proteinase endothiapepsin (EC 3.4.23.6), has been
determined by X-ray diffraction at 0.20-nm resolution and refined to an
agreement factor of 0.20. The inhibitor: Pro Thr Glu Phe-R-Phe Arg Glu (R =
-CH2NH-) is based on a chromogenic substrate of pepsin (EC 3.4.23.1). It has, in
place of the scissile bond, a reduced peptide group which is resistant to
hydrolysis and mimics the tetrahedral transition state. The inhibitor binds in
an extended conformation with the reduced bond close to the essential aspartate
side-chains of the enzyme. The hydrogen bonds and hydrophobic interactions
between the enzyme and the inhibitor do not induce large conformational changes.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
P.Liu,
M.R.Marzahn,
A.H.Robbins,
H.Gutiérrez-de-Terán,
D.Rodríguez,
S.H.McClung,
S.M.Stevens,
C.A.Yowell,
J.B.Dame,
R.McKenna,
and
B.M.Dunn
(2009).
Recombinant plasmepsin 1 from the human malaria parasite plasmodium falciparum: enzymatic characterization, active site inhibitor design, and structural analysis.
|
| |
Biochemistry,
48,
4086-4099.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.S.Andreeva,
and
L.D.Rumsh
(2001).
Analysis of crystal structures of aspartic proteinases: on the role of amino acid residues adjacent to the catalytic site of pepsin-like enzymes.
|
| |
Protein Sci,
10,
2439-2450.
|
 |
|
|
|
|
 |
C.Abad-Zapatero,
R.Goldman,
S.W.Muchmore,
C.Hutchins,
K.Stewart,
J.Navaza,
C.D.Payne,
and
T.L.Ray
(1996).
Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: implications for the design of antifungal agents.
|
| |
Protein Sci,
5,
640-652.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.Houen,
M.T.Madsen,
K.W.Harlow,
P.Lønblad,
and
B.Foltmann
(1996).
The primary structure and enzymic properties of porcine prochymosin and chymosin.
|
| |
Int J Biochem Cell Biol,
28,
667-675.
|
 |
|
|
|
|
 |
M.Marraud,
and
A.Aubry
(1996).
Crystal structures of peptides and modified peptides.
|
| |
Biopolymers,
40,
45-83.
|
 |
|
|
|
|
 |
V.Grand,
A.Aubry,
V.Dupont,
A.Vicherat,
and
M.Marraud
(1996).
Folded structures in protonated reduced dipeptides.
|
| |
J Pept Sci,
2,
381-391.
|
 |
|
|
|
|
 |
C.Rao-Naik,
K.Guruprasad,
B.Batley,
S.Rapundalo,
J.Hill,
T.Blundell,
J.Kay,
and
B.M.Dunn
(1995).
Exploring the binding preferences/specificity in the active site of human cathepsin E.
|
| |
Proteins,
22,
168-181.
|
 |
|
|
|
|
 |
D.Bailey,
and
J.B.Cooper
(1994).
A structural comparison of 21 inhibitor complexes of the aspartic proteinase from Endothia parasitica.
|
| |
Protein Sci,
3,
2129-2143.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.S.Abdel-Meguid
(1993).
Inhibitors of aspartyl proteinases.
|
| |
Med Res Rev,
13,
731-778.
|
 |
|
|
|
|
 |
A.Sali,
B.Veerapandian,
J.B.Cooper,
D.S.Moss,
T.Hofmann,
and
T.L.Blundell
(1992).
Domain flexibility in aspartic proteinases.
|
| |
Proteins,
12,
158-170.
|
 |
|
|
|
|
 |
J.A.Hartsuck,
G.Koelsch,
and
S.J.Remington
(1992).
The high-resolution crystal structure of porcine pepsinogen.
|
| |
Proteins,
13,
1.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.Suguna,
E.A.Padlan,
R.Bott,
J.Boger,
K.D.Parris,
and
D.R.Davies
(1992).
Structures of complexes of rhizopuspepsin with pepstatin and other statine-containing inhibitors.
|
| |
Proteins,
13,
195-205.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
W.J.Greenlee
(1990).
Renin inhibitors.
|
| |
Med Res Rev,
10,
173-236.
|
 |
|
|
|
|
 |
A.Sali,
B.Veerapandian,
J.B.Cooper,
S.I.Foundling,
D.J.Hoover,
and
T.L.Blundell
(1989).
High-resolution X-ray diffraction study of the complex between endothiapepsin and an oligopeptide inhibitor: the analysis of the inhibitor binding and description of the rigid body shift in the enzyme.
|
| |
EMBO J,
8,
2179-2188.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |